Literature DB >> 18184944

When epilepsy interferes with word comprehension: findings in Landau-Kleffner syndrome.

Eduardo M Castillo1, Ian J Butler, James E Baumgartner, Antony Passaro, Andrew C Papanicolaou.   

Abstract

Landau-Kleffner syndrome is characterized by a regression in receptive language. The factors that affect the clinical expression of this syndrome remain unclear. This study presents neuroimaging findings in 2 patients showing different clinical evolutions. Linguistic regression persisted in 1 patient and evolved positively in the other. In patient A (with severe linguistic regression) there was an overlap between areas engaged during word recognition and those involved in generating the epileptiform activity; in patient B (with better linguistic evolution), receptive language was predominantly represented in the right hemisphere (unaffected). Patient A underwent multiple subpial transections. The 2-year follow-up indicated linguistic improvement, absence of epileptiform activity, and activation of the left temporal cortex during word comprehension. These results suggest that the resolution of the linguistic deficit in Landau-Kleffner syndrome may be modulated by the language-specific cortex freed from interfering epileptiform activity or by reorganization of the receptive language cortex triggered by the epileptic activity.

Entities:  

Mesh:

Year:  2008        PMID: 18184944     DOI: 10.1177/0883073807308701

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  2 in total

Review 1.  What is more harmful, seizures or epileptic EEG abnormalities? Is there any clinical data?

Authors:  Gregory L Holmes
Journal:  Epileptic Disord       Date:  2014-10       Impact factor: 1.819

2.  Physical Feature Encoding and Word Recognition Abilities Are Altered in Children with Intractable Epilepsy: Preliminary Neuromagnetic Evidence.

Authors:  Maria Pardos; Milena Korostenskaja; Jing Xiang; Hisako Fujiwara; Ki H Lee; Paul S Horn; Anna Byars; Jennifer Vannest; Yingying Wang; Nat Hemasilpin; Douglas F Rose
Journal:  Behav Neurol       Date:  2015-06-03       Impact factor: 3.342

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.